Despite a 20% stock decline, we maintain a bullish view on UiPath due to its strategic pivot to Agentic AI and strong ...

UiPath announced the launch of its generative AI-based UiPath Medical Record Summarization agent, powered by Google Cloud ...

Both APP and PATH are technology companies leveraging artificial intelligence to enhance their platforms. Which one is a ...

Founders stepping aside for outside CEOs and then returning as CEO later on is quite a trope in the tech world, and Daniel ...

UiPath focuses on agentic automation, boasts a large ARR base, and has high gross margins. Click here to read why PATH stock ...

A new medical summarization AI agent will help healthcare organizations reduce overall prior authorization turn-around time by up to 50% UiPath will demo Vertex AI integration and showcase ...

UiPath (PATH) announced at Google Cloud Next 2025 the launch of its generative AI-based UiPath Medical Record Summarization agent, powered by ...

UiPath launches AI-based Medical Record Summarization tool, reducing processing time from 45 minutes to minutes. Powered by Google Cloud, the agent improves accuracy, saves 40 minutes per referral ...

A new medical summarization AI agent will help healthcare organizations reduce overall prior authorization turn-around time by up to 50% Dubai, United Arab Emirates – UiPath (NYSE: PATH), a leading ...

A new medical summarisation AI agent will help healthcare organisations reduce overall prior authorisation turn-around time by up to 50% The UiPath Medical Record Summarisation AI agent ...

But there’s a lot more going on with UiPath than C-suite shuffles — the company was founded to sell automation software. That entire market is being upended by AI, particularly agentic AI ...